Sung Lee
Director; EVP, Chief Financial Officer · 7 filings · Latest: Jun 29, 2026
CYTOKINETICS INC
Tango Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CYTK | Sung Lee | EVP, Chief Financial Officer | Jun 24, 2026 | Sale | $82.30 | 38,730 | $3.2M | 63,221 | |
CYTK | Sung Lee | EVP, Chief Financial Officer | Jun 24, 2026 | Option Exercise | $47.10 | 38,730 | $1.8M | 101,951 | |
CYTK | Sung Lee | EVP, Chief Financial Officer | Jun 29, 2026 | Sale | $85.00 | 3,134 | $266.4K | 63,221 | |
CYTK | Sung Lee | EVP, Chief Financial Officer | Jun 29, 2026 | Option Exercise | $45.83 | 3,134 | $143.6K | 66,355 | |
CYTK | Sung Lee | — | Jun 29, 2026 | Proposed Sale | $82.19 | 9,503 | $781.1K | — | |
CYTK | Sung Lee | — | Jun 26, 2026 | Proposed Sale | $80.80 | 6,695 | $541.0K | — | |
CYTK | Sung Lee | — | Jun 24, 2026 | Proposed Sale | $80.01 | 38,730 | $3.1M | — | |
CYTK | SUNG LEE | — | May 5, 2026 | Proposed Sale | $66.05 | 23,906 | $1.6M | — | |
CYTK | Sung Lee | EVP, Chief Financial Officer | May 5, 2026 | Sale | $76.87 | 23,906 | $1.8M | 63,221 | |
CYTK | Sung Lee | EVP, Chief Financial Officer | Mar 17, 2026 | Sale | $62.15 | 4,935 | $306.7K | 87,127 |